Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5)

Scandinavian Journal of Immunology

Volumn 52, Issue 4, 2000, Pages 369-379

  Jagannath, C ^a,b   Hoffmann, H ^a,b   Sepulveda, E ^a,b   Actor, J K ^a,b   Wetsel, R A ^a,b   Hunter Jr , R L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COMPLEMENT COMPONENT C5; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL KILLING; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; INFECTION SENSITIVITY; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANIMALS; CHEMOKINES; COMPLEMENT C5; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HYDROGEN PEROXIDE; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; TUBERCULOSIS;

EID: 0033834379     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00770.x     Document Type: Article

References (49)

1. Diseases in mice and rats
2. Relative immunogenicity of virulent and attenuated strains of tubercle bacilli
3. Mouse model of tuberculosis
4. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology and cause mortality in mice
5. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp 1 genotype
6. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
7. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice
8. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections
9. Lethal tuberculosis in interleukin-6-deficient mutant mice
10. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
11. Increased antimycobacterial immunity in interleukin-10-deficient mice
12. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice
13. Growth rate of Mycobacteria in mice as an unreliable indicator of mycobacterial virulence
14. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates
15. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: Effects on growth in culture and in macrophages
16. Distribution, inheritance and properties of an antigen MUB1 and its relation to hemolytic complement
17. Deficiency of the murine fifth complement component (C5) a 2 base pair gene deletion in a 5' exon
18. Mycobacterium tuberculosis and the complement system
19. A macrophage invasion mechanism of pathogenic Mycobacteria
20. Ethambutol and dimethyl sulfoxide enhance drug susceptibility in multi-drug resistant Mycobacterium tuberculosis
21. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis: In vitro, intracellular and in vivo studies
22. Induction of nitric oxide in human monocytes and monocyte derived cell lines by Mycobacterium tuberculosis
23. CRL-1072 enhances anti-mycobacterial activity of human macrophages through IL-8
24. Minimal effect of advanced aging on the susceptibility of mice to infection with Mycobacterium tuberculosis
25. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route
26. Antituberculosis drugs: Antimicrobial activity in vitro
27. In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha
28. Recombinant inbred mouse strains derived from A/J and C57BL/6J: A tool for the study of genetic mechanisms in host resistance to infection and malignancy
29. Relationship between survival, organism containment and granuloma formation in acute murine tuberculosis
30. Apoptosis in Mycobacterium tuberculosis infection in mice exibiting varied pathology
31. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity
32. Detection of viable and non viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR against antigen 85 complex B mRNA
33. A mouse model of the recrudescence of latent tuberculosis in the elderly
34. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues
35. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli
36. Effects of aminoguanidine on latent murine tuberculosis
37. The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis
38. Reactivation of latent tuberculosis: Variations on the Cornell murine model
39. A mouse model for latent tuberculosis
40. Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes
41. Complement and complement deficiencies
42. Macrophages and tuberculosis
43. Human recombinant C5a enhances lipopolysaccharide-induced synthesis of interleukin-6 by human monocytes
44. Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Translational signal provided by lipopolysaccharide or IL-1 itself
45. NF-kappaB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells
46. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis
47. Endothelial cell E and P-selectin upregulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence
48. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells
49. Cytokine/chemokine cascades in immunity to tuberculosis